Documentation Requirements in Non-acute Care Facilities and Organizations Books
Product Description
This is an exceptionally well-organized, complete classroom textbook on non-acute care documentation requirements for students taking undergraduate courses in health in rank management (HIM) and health in rank technology (HIT) programs. The only text on documentation requirements for non-acute care facilities, the book contains chapters on ambulatory care, including sickbay-based ambulatory care and physician offices, as well as ambulatory care in homes, hospices and correctional facilities. It covers documentation requirements for post acute (subacute) care, long-term care and behavioral health care. The text contains two chapters on documentation requirements for remedy services: corporal remedy and chemical addiction remedy. Author Barbara J. Manger, assistant professor in the Health In rank Management Program at Kean University, also provides samples of forms used at different sites, in rank about applicable accreditation standards and their implications, references to official documents and accreditation manuals, a list of abbreviations, and an index.
Buy Cheap Documentation Requirements in Non-acute Care Facilities and Organizations Online
21st Century Adult Cancer Sourcebook: Chronic Myelogenous Leukemia – Clinical Data for Patients, Families, and Physicians Books
Product Description
Authoritative in rank and matter-of-fact advice from the nation’s cancer experts about chronic myelogenous leukemia (CML) includes official medical data on signs, symptoms, early detection, diagnostic testing, risk factors and prevention, treatment options, surgery, radiation, drugs, chemotherapy, production, biology, prognosis, and survival, with a complete glossary of technical medical terms and current references. Starting with the basics, and advancing to detailed patient-oriented and physician-quality in rank, this comprehensive in-depth compilation gives empowered patients, families, caregivers, nurses, and physicians the knowledge they need to know the diagnosis and treatment of CML.
Comprehensive data on clinical trials correlated to CML is included – - with in rank on intervention, sponsor, gender, age group, trial phase, number of enrolled patients, funding source, study type, study design, NCT identification number and other IDs, first received date, start date, completion date, primary completion date, last updated date, last verified date, associated acronym, and outcome measures.
Chronic myelogenous leukemia is a disease in which the bone marrow makes too many white blood cells. Chronic myelogenous leukemia (also called CML or chronic granulocytic leukemia) is a slowly progressing blood and bone marrow disease that ordinarily occurs during or after middle age, and seldom occurs in children. Normally, the bone marrow makes blood stem cells (immature cells) that develop into mature blood cells over time. A blood stem cell may become a myeloid stem cell or a lymphoid stem cell. The lymphoid stem cell develops into a white blood cell. The myeloid stem cell develops into one of three types of mature blood cells: Red blood cells that carry oxygen and other materials to all tissues of the body. Platelets that help preclude bleeding by causing blood clots to form. Granulocytes (white blood cells) that fight infection and disease. In CML, too many blood stem cells develop into a type of white blood cell called granulocytes. These granulocytes are abnormal and do not become healthy white blood cells. They may also be called leukemic cells. The leukemic cells can build up in the blood and bone marrow so there is less room for healthy white blood cells, red blood cells, and platelets. When this happens, infection, anemia, or simple bleeding may occur. Possible signs of chronic myelogenous leukemia include tiredness, night sweats, and fever.
At the time of diagnosis of patients with CML, splenomegaly is the most common finding on corporal examination. The spleen may be enormous, filling most of the abdomen and presenting a significant clinical problem, or the spleen may be only minimally enlarged. In about 10% of patients, the spleen is neither palpable nor enlarged on splenic scan.
Extensive supplements, with chapters gathered from our Cancer Toolkit run and other reports, cover a broad range of cancer topics helpful to cancer patients. This edition includes our exclusive Guide to Leading Medical Websites with updated links to 81 of the best sites for medical in rank, which let you quickly check for updates from the government and the best commercial portals, news sites, reference/textbook/non-commercial portals, and health organizations. Supplemental coverage includes:
Levels of Evidence for Cancer Treatment Studies
Glossary of Clinical Trial Terms
Clinical Trials Background In rank and In-Depth Program
Clinical Trials at NIH
How To Find A Cancer Treatment Trial: A Ten-Step Guide
Taking Part in Cancer Treatment Research Studies
Access to Investigational Drugs
Clinical Trials Conducted by the National Cancer Institute’s Focal top for Cancer Research at the National Institutes of Health Clinical Focal top
Taking Time: Support for People with Cancer
Facing Forward – Life After Cancer Treatment
Chemotherapy and YouProduct Description
Authoritative in rank and matter-of-fact advice from the nation’s cancer experts about chronic myelogenous leukemia (CML) includes official medical data on signs, symptoms, early detection, diagnostic testing, risk factors and prevention, treatment options, surgery, radiation, drugs, chemotherapy, production, biology, prognosis, and survival, with a complete glossary of technical medical terms and current references. Starting with the basics, and advancing to detailed patient-oriented and physician-quality in rank, this comprehensive in-depth compilation gives empowered patients, families, caregivers, nurses, and physicians the knowledge they need to know the diagnosis and treatment of CML.
Comprehensive data on clinical trials correlated to CML is included – - with in rank on intervention, sponsor, gender, age group, trial phase, number of enrolled patients, funding source, study type, study design, NCT identification number and other IDs, first received date, start date, completion date, primary completion date, last updated date, last verified date, associated acronym, and outcome measures.
Chronic myelogenous leukemia is a disease in which the bone marrow makes too many white blood cells. Chronic myelogenous leukemia (also called CML or chronic granulocytic leukemia) is a slowly progressing blood and bone marrow disease that ordinarily occurs during or after middle age, and seldom occurs in children. Normally, the bone marrow makes blood stem cells (immature cells) that develop into mature blood cells over time. A blood stem cell may become a myeloid stem cell or a lymphoid stem cell. The lymphoid stem cell develops into a white blood cell. The myeloid stem cell develops into one of three types of mature blood cells: Red blood cells that carry oxygen and other materials to all tissues of the body. Platelets that help preclude bleeding by causing blood clots to form. Granulocytes (white blood cells) that fight infection and disease. In CML, too many blood stem cells develop into a type of white blood cell called granulocytes. These granulocytes are abnormal and do not become healthy white blood cells. They may also be called leukemic cells. The leukemic cells can build up in the blood and bone marrow so there is less room for healthy white blood cells, red blood cells, and platelets. When this happens, infection, anemia, or simple bleeding may occur. Possible signs of chronic myelogenous leukemia include tiredness, night sweats, and fever.
At the time of diagnosis of patients with CML, splenomegaly is the most common finding on corporal examination. The spleen may be enormous, filling most of the abdomen and presenting a significant clinical problem, or the spleen may be only minimally enlarged. In about 10% of patients, the spleen is neither palpable nor enlarged on splenic scan.
Extensive supplements, with chapters gathered from our Cancer Toolkit run and other reports, cover a broad range of cancer topics helpful to cancer patients. This edition includes our exclusive Guide to Leading Medical Websites with updated links to 81 of the best sites for medical in rank, which let you quickly check for updates from the government and the best commercial portals, news sites, reference/textbook/non-commercial portals, and health organizations. Supplemental coverage includes:
Levels of Evidence for Cancer Treatment Studies
Glossary of Clinical Trial Terms
Clinical Trials Background In rank and In-Depth Program
Clinical Trials at NIH
How To Find A Cancer Treatment Trial: A Ten-Step Guide
Taking Part in Cancer Treatment Research Studies
Access to Investigational Drugs
Clinical Trials Conducted by the National Cancer Institute’s Focal top for Cancer Research at the National Institutes of Health Clinical Focal top
Taking Time: Support for People with Cancer
Facing Forward – Life After Cancer Treatment
Chemotherapy and You
Buy Cheap 21st Century Adult Cancer Sourcebook: Chronic Myelogenous Leukemia – Clinical Data for Patients, Families, and Physicians Online
Workplace Drug Testing Books
Product Description
This comprehensive text provides clear explanations of the effects of drugs on human performance and the need for workplace drug testing. Case studies of successful programmes are included as well as how different countries test for drugs. It provides essential in rank on: the regulatory and legal frameworks nearly the world; how to set policies and coverage of all aspects of drug analysis; and the associated interpretation of consequences. Written by internationally acknowledged experts this informative book is essential reading for anyone interested in workplace drug testing or setting up such a system including clinical and forensic toxicologists, occupational health physicians, nurses, human resources, drug counselling and treatment providers, analytical chemists and lawyers.
Buy Cheap Workplace Drug Testing Online
Neurological Therapeutics: Principles and Do, 2 Volume Set Books
Product Description
A two-volume reference, this book covers all aspects of pharmaceutical and interventional therapy for neurological diseases and disorders. The editor has assembled a panel of experts who examine therapies are now available, how effective they are, and probable consequences. The contributors are well-known in their subspecialties and contribute private experience. Leading neurologists are section editors, and they in turn have chosen leaders from all the neurological subspecialties. Neurologists, psychiatrists, geriatricians, and pediatricians will consult this book for both rare and common diseases and disorders, whether their patients are elderly, middle-aged, or youthful.
Buy Cheap Neurological Therapeutics: Principles and Do, 2 Volume Set Online
